Definitive Contract 140D6318C0027
- Not listed
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, for the development of a "Point of Care Host-Pathogen Monitoring System." The fixed-price contract has a ceiling value of $149,503.39 and was awarded on November 18, 2016, with a completion date of November 27, 2017. Mbio Diagnostics Inc. is a for-profit organization that develops...
- Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, has been awarded a firm fixed-price purchase order valued at $5,654,478 by the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (HHS ASPR). The base period of performance for this contract is from February 3, 2021 through February 2, 2022. Under the contract, Lightdeck Diagnostics will develop its Lightdeck SARS-CoV Ultra-Rapid Antigen Test to achieve Emergency Use Authorization...
- The U.S. Air Force awarded a $35,089,000 firm-fixed-price contract to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics, to scale up manufacturing capacity for ultra-rapid point-of-care COVID-19 tests. The contract, which has a completion date of March 31, 2023, does not have a set-aside designation. Mbio Diagnostics is a company that develops diagnostic tests and devices, including rapid point-of-care tests, using its proprietary Lightdeck platform technology. Through past prime...
- This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...
- This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...
- <p>The U.S. Defense Advanced Research Projects Agency (DARPA) awarded a Firm Fixed Price, Definitive Contract to Probiusdx Inc., a small business, for point-of-care monitoring of the host-pathogen interaction during infection. The contract has a ceiling value of $1,746,921.00 and a period of performance ending on November 15, 2021. This contract was awarded under DARPA's SBIR (Small Business Innovation Research) Program Phase II. The place of performance is Duncans Mills, CA.</p>
- This is a $999,923 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business in Sunnyvale, California. The contract is for the development of point-of-care diagnostic solutions to monitor the host-pathogen interaction during infection. Inflammatix has been awarded over $29 million in federal contracts and grants from agencies like the Department of Health and Human Services and...
- This is a $1,430,615.73 firm fixed-price Definitive Contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the "REAL-TIME ASSESSMENT OF ANTIMICROBIAL CONCENTRATIONS FOR PERSONALIZED TREATMENT OF INFECTIOUS DISEASES" and has an ultimate completion date of October 15, 2020. The contract was awarded on February 19, 2018 and is designated as a...
- The Defense Health Agency has awarded a $249,969 Small Business Innovation Research (SBIR) Phase I contract to Emergingdx Inc., a Lowell, Massachusetts-based diagnostic technology company, for the development of an integrated multiplexed low-cost diagnostic platform for rapid microbial identification. This total small business set-aside contract, designated as a purchase order with firm fixed price terms, represents the initial phase of research and development aimed at advancing medical...
- The Department of the Air Force Materiel Command Research Laboratory awarded a $749,991 firm fixed price purchase order to Definitive Biotechnologies, LLC as part of the Small Business Innovation Research Program Phase II Action. Under this contract, Definitive Biotechnologies will deliver a disposable, multiplex molecular device for simultaneous point-of-care diagnosis of coronavirus disease 2019 and influenza. The contract has a total small business set aside designation. Performance will...
This is a $2,761,705.00 Firm Fixed Price Phase II Small Business Innovation Research (SBIR) contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Mbio Diagnostics Inc., doing business as Lightdeck Diagnostics. The contract is for the development of point-of-care monitoring of the host-pathogen interaction during infection. Mbio Diagnostics Inc. is a company that develops diagnostic tests and devices, including rapid point-of-care tests, using its proprietary Lightdeck platform technology. Through past federal contract awards and grants, Mbio Diagnostics Inc. has provided a variety of goods and services related to diagnostic test development, manufacturing, and distribution, primarily focused on supporting the coronavirus/COVID-19 response.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00008 | Close Out | $0 | 2/1/23 | |
| P00007 | Supplemental Agreement for work within scope | $0 | 3/31/21 | |
| P00006 | Supplemental Agreement for work within scope | $0 | 10/23/20 | |
| P00005 | Supplemental Agreement for work within scope | $0 | 6/12/20 | |
| P00004 | Supplemental Agreement for work within scope | $1.6m | 3/4/20 |